These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29994983)

  • 41. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
    Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C
    Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial.
    Rostaing L; Bunnapradist S; Grinyó JM; Ciechanowski K; Denny JE; Silva HT; Budde K;
    Am J Kidney Dis; 2016 Apr; 67(4):648-59. PubMed ID: 26717860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Variability index of tacrolimus serum levels in pediatric liver transplant recipients younger than 12 years: Non-adherence or risk of non-adherence?
    de Oliveira JTP; Kieling CO; da Silva AB; Stefani J; Witkowski MC; Smidt CR; Mariano da Rocha CR; Hirakata VN; Grossini MDG; Zanotelli ML; Gonçalves Vieira SM
    Pediatr Transplant; 2017 Dec; 21(8):. PubMed ID: 29034612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adverse effects of mycophenolic acid in renal transplant recipients: gender differences.
    Spasić A; Catić-Đorđević A; Veličković-Radovanović R; Stefanović N; Džodić P; Cvetković T
    Int J Clin Pharm; 2019 Jun; 41(3):776-784. PubMed ID: 31028595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conversion to prolonged release tacrolimus formulation in stable kidney transplant recipients.
    Wu SW; Tsai HC; Tsai PY; Hung TW; Chang HR; Lian JD
    Swiss Med Wkly; 2013; 143():w13850. PubMed ID: 23986367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of an electronic medication monitoring device to estimate medication adherence in kidney transplant patients.
    Krause AV; Bertram A; Nöhre M; Bauer-Hohmann M; Schiffer M; de Zwaan M
    Transl Behav Med; 2021 Apr; 11(3):842-851. PubMed ID: 33710349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes of underweight, overweight, and obese pediatric kidney transplant recipients.
    Kaur K; Jun D; Grodstein E; Singer P; Castellanos L; Teperman L; Molmenti E; Fahmy A; Frank R; Infante L; Sethna CB
    Pediatr Nephrol; 2018 Dec; 33(12):2353-2362. PubMed ID: 30136105
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction Therapy, Rejection, and Graft Outcomes in Pediatric and Adolescent Kidney Transplant Recipients.
    Mincham CM; Wong G; Teixeira-Pinto A; Kennedy S; Alexander S; Larkins N; Lim WH
    Transplantation; 2017 Sep; 101(9):2146-2151. PubMed ID: 28832451
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interventions to improve medication adherence in adult kidney transplant recipients: a systematic review.
    Low JK; Williams A; Manias E; Crawford K
    Nephrol Dial Transplant; 2015 May; 30(5):752-61. PubMed ID: 24950938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predicting medication adherence and employment status following kidney transplant: The relative utility of traditional and everyday cognitive approaches.
    Gelb SR; Shapiro RJ; Thornton WJ
    Neuropsychology; 2010 Jul; 24(4):514-26. PubMed ID: 20604625
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Daytime sleepiness in renal transplant recipients is associated with immunosuppressive non-adherence: a cross-sectional, multi-center study.
    Burkhalter H; Wirz-Justice A; Cajochen C; Weaver TE; Steiger J; Fehr T; Venzin RM; De Geest S
    Clin Transplant; 2014 Jan; 28(1):58-66. PubMed ID: 24325281
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence.
    Venkat VL; Nick TG; Wang Y; Bucuvalas JC
    Pediatr Transplant; 2008 Feb; 12(1):67-72. PubMed ID: 18186891
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic Monitors.
    Sayner R; Carpenter DM; Blalock SJ; Robin AL; Muir KW; Hartnett ME; Giangiacomo AL; Tudor G; Sleath B
    Clin Ther; 2015 Sep; 37(9):1975-85. PubMed ID: 26164785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mobile Technology Affinity in Renal Transplant Recipients.
    Reber S; Scheel J; Stoessel L; Schieber K; Jank S; Lüker C; Vitinius F; Grundmann F; Eckardt KU; Prokosch HU; Erim Y
    Transplant Proc; 2018; 50(1):92-98. PubMed ID: 29407338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pre-transplant history of mental health concerns, non-adherence, and post-transplant outcomes in kidney transplant recipients.
    Gumabay FM; Novak M; Bansal A; Mitchell M; Famure O; Kim SJ; Mucsi I
    J Psychosom Res; 2018 Feb; 105():115-124. PubMed ID: 29332627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
    Kuypers DR; Vanrenterghem Y
    Clin Ther; 2004 Nov; 26(11):1834-44. PubMed ID: 15639695
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.
    Alloway RR; Vinks AA; Fukuda T; Mizuno T; King EC; Zou Y; Jiang W; Woodle ES; Tremblay S; Klawitter J; Klawitter J; Christians U
    PLoS Med; 2017 Nov; 14(11):e1002428. PubMed ID: 29135993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multimethod Assessment of Medication Nonadherence and Barriers in Adolescents and Young Adults With Solid Organ Transplants.
    Eaton CK; Gutierrez-Colina AM; Quast LF; Liverman R; Lee JL; Mee LL; Reed-Knight B; Cushman G; Chiang G; Romero R; Mao C; Garro R; Blount RL
    J Pediatr Psychol; 2018 Aug; 43(7):789-799. PubMed ID: 29562247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study.
    Bhatia S; Landier W; Hageman L; Chen Y; Kim H; Sun CL; Kornegay N; Evans WE; Angiolillo AL; Bostrom B; Casillas J; Lew G; Maloney KW; Mascarenhas L; Ritchey AK; Termuhlen AM; Carroll WL; Wong FL; Relling MV
    JAMA Oncol; 2015 Jun; 1(3):287-95. PubMed ID: 26181173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The transplant team's support of kidney transplant recipients to take their prescribed medications: a collective responsibility.
    Williams A; Low JK; Manias E; Crawford K
    J Clin Nurs; 2016 Aug; 25(15-16):2251-61. PubMed ID: 27264024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.